(Q52884721)

English

Course of iron parameters in HFE-hemochromatosis patients during initial treatment with erythrocytapheresis compared to phlebotomy.

scientific article published on 16 February 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

Course of iron parameters in HFE-hemochromatosis patients during initial treatment with erythrocytapheresis compared to phlebotomy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

author name string

Eva Rombout-Sestrienkova

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

Ger H Koek

2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

Rabin Neslo

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

Marian van Kraaij

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

Paul P Menheere

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

Ad Masclee

6

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

Dorine W Swinkels

7

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

publication date

16 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

Journal of Clinical Apheresis

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

31

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

6

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

564-570

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Hereditary hemochromatosis: genetic complexity and new diagnostic approaches

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Hepcidin and iron homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Hepcidin in human iron disorders: diagnostic implications

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Diagnosis and management of hereditary haemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

How I treat hemochromatosis.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

EASL clinical practice guidelines for HFE hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis - A pilot study

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Optimal management strategies for chronic iron overload.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Molecular liaisons between erythropoiesis and iron metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Regulation of hepcidin: insights from biochemical analyses on human serum samples

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Serum hepcidin: reference ranges and biochemical correlates in the general population

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

A survey of phlebotomy among persons with hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21451

21 January 2018

Identifiers

10.1002/JCA.21451

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26878994

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52884721&oldid=2098648813"